Funded Tech Companies
Dyne Therapeutics
Wondering who provided funding to Dyne Therapeutics? Forbion Capital Partners, Wellington Management Company and Atlas Venture joined the equity holders in this biopharmaceutical company.
Company Overview
Company Name
Dyne Therapeutics
Company Status
Publicly-held
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
830 Winter St.
Waltham, MA 02451
USA
Waltham, MA 02451
USA
Phone
Website
Email Address
Company Background Information
Overview
Dyne Therapeutics (Nasdaq: DYN) was founded with a singular focus: to transform the lives of people with serious muscle diseases by pioneering muscle-targeted therapies. Our proprietary technologies provide the foundation for breakthrough treatments. We have assembled a world-class team of experts who are united by their commitment to fulfill this mission.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
9/16/2020
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Joshua Brumm
Chief Operating Officer
Susanna High
Chief Scientific Officer
Romesh Subramanian
Vice President
John Davis
Vice President
Molly White
Vice President
Daniel Wilson
VP - Administration
Rick Scalzo
VP - Bus. Development
Jonathan McNeill
VP - Bus. Development
Chris Mix
VP - Finance
Gene Kim
VP - Manufacturing
John Najim
VP - R & D
Oxana Beskrovnaya
VP - R & D
Mo Qatanani
VP - Regulatory Affairs
Debra Feldman
Company Investors
- Forbion Capital Partners (Dirk Kersten)
- Wellington Management Company
- Atlas Venture (Jason Rhodes)
- Logos Capital
- MPM Capital (Ed Hurwitz)
- Vida Ventures
- Franklin Templeton
- Surveyor Capital
Browse more funded tech companies:
Share this article
About Our Venture Capital Database
This tech company profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs